Skip to main content
. 2018 Sep 27;2018(9):CD001506. doi: 10.1002/14651858.CD001506.pub4

Donaldson 2013.

Methods RCT.
Location: USA.
Duration: 4 weeks.
Participants Children with CF and stable lung disease (FEV1 > 60%) aged between 5 and 18 years.
24 screened, 23 randomised, 20 completed treatment and follow‐up.
Interventions Intervention: HS 6% 3x daily via eFlow nebuliser.
Control: IS 0.12% 3x daily via eFlow nebuliser.
Outcomes Primary outcome
Mucociliary clearance.
Secondary outcomes
Spirometry.
QoL (CFQ‐R).
Notes We are waiting for further data to judge whether this trial should be included.